The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab + bevacizumab versus lenvatinib as first-line systemic therapy for treatment of hepatocellular carcinoma in a real-world population: Outcomes from the HCC CHORD database.
 
Mark Freeman
Stock and Other Ownership Interests - Abbott Laboratories; Abbott Laboratories (I); Abbvie; Abbvie (I); Agilent; Agilent (I); Align Technology; Align Technology (I); Amgen; Amgen (I); Baxter International Foundation; Baxter International Foundation (I); Becton Dickinson; Becton Dickinson (I); Bio-Rad; Bio-Rad (I); Bio-Techne; Bio-Techne (I); Biogen; Biogen (I); Boston Scientific; Boston Scientific (I); Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation (I); Cardinal Health; Cardinal Health (I); Catalent; Catalent (I); Cencora; Cencora (I); Centene; Centene (I); Charles River Laboratories; Charles River Laboratories (I); Cigna; Cigna (I); CooperCompanies; CooperCompanies (I); CVS Health; CVS Health (I); Danaher; Danaher (I); DaVita; DaVita (I); Dentsply International; Dentsply International (I); Dexcom; Dexcom (I); Edwards Lifesciences; Edwards Lifesciences (I); Elevance Health; Elevance Health (I); GE Healthcare; GE Healthcare (I); Gilead Sciences; Gilead Sciences (I); HCA Healthcare; HCA Healthcare (I); Henry Schein; Henry Schein (I); Hologic; Hologic (I); Humana; Humana (I); IDEXX Laboratories; IDEXX Laboratories (I); Illumina; Illumina (I); Incyte; Incyte (I); Insulet Corporation; Insulet Corporation (I); Intuitive Surgical; Intuitive Surgical (I); IQvia; IQvia (I); Johnson & Johnson; Johnson & Johnson (I); LabCorp; LabCorp (I); Lilly; Lilly (I); McKesson; McKesson (I); Medtronic; Medtronic (I); Merck; Merck (I); Mettler Toledo; Mettler Toledo (I); Moderna Therapeutics; Moderna Therapeutics (I); Molina Healthcare; Molina Healthcare (I); Pfizer; Pfizer (I); Quest Diagnostics; Quest Diagnostics (I); Regeneron; Regeneron (I); ResMed; ResMed (I); Revvity; Revvity (I); STERIS; STERIS (I); Stryker; Stryker (I); Teleflex Medical; Teleflex Medical (I); Thermo Fisher Scientific; Thermo Fisher Scientific (I); UnitedHealth; UnitedHealth; Universal Health Services; Universal Health Services (I); Vertex; Vertex (I); Viatris; Viatris (I); Waters Corporation; Waters Corporation (I); West Pharmaceutical; West Pharmaceutical (I); Zimmer BioMet; Zimmer BioMet (I); Zoetis; Zoetis (I)
 
Tharani Krishnan
No Relationships to Disclose
 
Cha Len LEE
No Relationships to Disclose
 
Pooya Dibajnia
No Relationships to Disclose
 
Ravi Ramjeesingh
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Incyte; Ipsen; Knight Pharmaceuticals; Lilly; Merck; Novartis Canada Pharmaceuticals Inc; Roche; Shire
Consulting or Advisory Role - AstraZeneca Canada; Bayer; Celgene; Incyte; ipsen; Janssen; Roche; SERVIER; Shire
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Eisai (Inst); Ipsen; Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Novartis; Novartis Canada Pharmaceuticals Inc; Pfizer
 
Joao Paulo Solar Vasconcelos
No Relationships to Disclose
 
Hanna Lyubetska
No Relationships to Disclose
 
Philip Q. Ding
No Relationships to Disclose
 
Howard J Lim
Honoraria - Amgen; Astellas Pharma; AstraZeneca Canada; BMS Canada; Dicephera Pharmaceuticals, Inc.; eisai; Ipsen; Merck; Roche Canada; Taiho Pharmaceutical; Varian Medical Systems
Research Funding - Roche (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Eisai; Taiho Oncology
 
Jennifer J. Knox
Honoraria - AstraZeneca; Incyte; Ipsen; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca; Incyte
 
Brandon M. Meyers
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Incyte; Ipsen; Merck; Roche Canada; Sanofi; SERVIER
Speakers' Bureau - Eisai
Research Funding - Eisai/MSD (Inst); Exelixis/Ipsen (Inst); Galera Therapeutics (Inst); Roche Canada (Inst)
Expert Testimony - Roche Canada
 
Vallerie Lynn Gordon
Consulting or Advisory Role - AAA Canada; Incyte; Knight Therapeutics
 
Winson Y. Cheung
No Relationships to Disclose
 
Vincent C. Tam
Honoraria - AstraZeneca; Eisai; Incyte; Ipsen; Merck; Roche Canada
Research Funding - AstraZeneca (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Merck (Inst); Roche Canada (Inst)
Expert Testimony - AstraZeneca Canada; Incyte